CompletedNot Applicable

Prevalence and Risk Factors Nocturnal Polyuria in Female OAB

1,071 participantsStarted 2009-07-01

Plain-language summary

Nocturnal polyuria may decrease the treatment efficacy of overactive bladder syndrome (OAB); and adjuvant medication, such as desmopressin, may be needed for the treatment of nocturnal polyuria. The knowledge of prevalence and risk factors of nocturnal polyuria might be important for the treatment of OAB. Thus, our aim is to describe the prevalence and risk factors of nocturnal polyuria in women with OAB.

Who can participate

Age range20 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. More than 20-year-old
✓. Female
✓. Diagnosed with overactive bladder

Exclusion criteria

✕. Younger than 20-year-old
✕. Pregnant or planned to be pregnant

What they're measuring

Nocturnal polyuria

Timeframe: Between July 2009 and January 2018

Trial details

NCT IDNCT03810027

SponsorNational Taiwan University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-01-31

View on ClinicalTrials.gov More Nocturia trials